Toronto Dominion Bank’s Oncorus, Inc. ONCR Stock Holding History

Toronto Dominion Bank’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2	Closed	–	–	2047
2022 Q1	$0	Hold	2	–	–	﹤0.01%	2167
2021 Q4	$0	Buy	+2	New	+$15	﹤0.01%	2147

Other funds holding ONCR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Toronto Dominion Bank's ONCR Position: Q2 2022 in Review

Toronto Dominion Bank sold out of Oncorus, Inc. (ONCR) in Q2 2022, closing a stake of 2 shares.

Toronto Dominion Bank first reported a position in ONCR in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 45 funds tracked by Wall St. Rank hold ONCR as of Q2 2022.

Toronto Dominion Bank reported no remaining Oncorus, Inc. position as of Q2 2022 after selling out during the quarter.
Toronto Dominion Bank sold 2 Oncorus, Inc. shares in Q2 2022.
Toronto Dominion Bank first reported a position in Oncorus, Inc. in Q4 2021 and held it in 2 quarters.
Toronto Dominion Bank's Oncorus, Inc. position peaked at $0 in Q1 2022.
45 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.